89Bio Inc reports results for the quarter ended in June - Earnings Summary

89bio

09/08/2023 21:49

* 89Bio Inc  ETNB.OQ  reported a quarterly adjusted loss
of 52
cents​​ per share for the quarter ended in June. The mean
expectation of eight analysts for the quarter was for a loss
of 41 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * 89Bio Inc's reported EPS for the quarter was a loss of 52
cents​.
    * The mean earnings estimate of analysts had risen by
about 6.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * 89Bio Inc shares had fallen by 17.7% this quarter and
gained 22.5% so far this year.
    * The company reported a quarterly loss of $38.39 million.
    * Wall Street's median 12-month price target for 89Bio Inc
is
$35.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 08:49 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.41          -0.52          Missed
 Mar. 31 2023      -0.52          -0.54          Missed
 Dec. 31 2022      -0.69          -0.48          Beat
 Sep. 30 2022      -0.80          -0.57          Beat